BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

ARISTEIA CAPITAL, L.L.C.'s Holding History (CIK: 0001080171)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 28,000,000 Value ($000) $26,208 Avg Close — Range —
Q1 2025
Shares 30,000,000 Value ($000) $27,045 Avg Close — Range —
Q4 2024
Shares 30,000,000 Value ($000) $25,740 Avg Close — Range —
Q3 2024
Shares 34,280,000 Value ($000) $28,795 Avg Close — Range —
Q2 2024
Shares 30,780,000 Value ($000) $24,527 Avg Close — Range —
Q1 2024
Shares 30,780,000 Value ($000) $25,220 Avg Close — Range —
Q4 2023
Shares 40,780,000 Value ($000) $34,740 Avg Close — Range —
Q3 2023
Shares 25,280,000 Value ($000) $18,960 Avg Close — Range —
Q2 2023
Shares 30,280,000 Value ($000) $18,740 Avg Close — Range —
Q1 2023
Shares 45,280,000 Value ($000) $29,312 Avg Close — Range —
Q4 2022
Shares 40,816,000 Value ($000) $15,587 Avg Close — Range —
Q3 2022
Shares 40,816,000 Value ($000) $18,110 Avg Close — Range —
Q2 2022
Shares 29,316,000 Value ($000) $12,421 Avg Close — Range —
Q1 2022
Shares 31,816,000 Value ($000) $15,472 Avg Close — Range —